Shanghai-headquartered ophthalmology-focused pharma firm Ocumension Therapeutics on Tuesday made a stellar trading debut on the Hong Kong stock exchange with its shares soaring 152 per cent to reach a peak of HK$42.50 ($5.5) before closing at HK$38.20 ($4.9).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
